Navigation Links
Rescuing injured hearts by enhancing regeneration

Using a two-drug approach, researchers at Children's Hospital Boston have demonstrated that it may be possible to rescue heart function after a heart attack and protect the heart from scarring. Working with rats, they combined an agent that overcomes a natural inhibitor of cell division with a naturally occurring growth factor that encourages blood vessel growth (angiogenesis). Together, these two agents enabled heart-muscle cells to multiply and the heart to regain its function after a simulated myocardial infarction. The study will appear in the October 17 issue of the Proceedings of the National Academy of Sciences (posted online during the week of October 9).

Normally, after a heart attack, the damaged heart muscle cannot grow back and is instead replaced by scar tissue. Excessive scarring can impair the heart's pumping capacity and can lead to life-threatening arrhythmias. Heart-muscle cells (cardiomyocytes) normally cannot replicate in mammals, a major obstacle to regeneration. However, in a paper last year, Felix Engel, PhD, and Mark Keating, MD, in the Department of Cardiology at Children's Hospital Boston, showed that they could coax cardiomyocytes to multiply in a petri dish by inhibiting an enzyme known as p38 MAP kinase, which normally suppresses cardiomyocyte replication. [See: www.childrenshospital.org/newsroom/Site1339/mainpageS1339P1sublevel139.html]

Engel and Keating (Keating is now at the Novartis Institute for BioMedical Research) now build on this finding. They studied 120 rats, some with simulated heart attacks. After the injury, the animals were randomly assigned to receive injections with a p38 MAP kinase inhibitor alone, the angiogenesis stimulator FGF1 alone, both agents together, or saline (placebo) for four weeks. Three months later, rats that had received both FGF1 and the p38 MAP kinase inhibitor had markedly improved heart
'"/>

Source:Children's Hospital Boston


Page: 1 2 3

Related biology news :

1. Molecular messengers perform a crucial role in the ability of injured nerve cells to heal themselves
2. NASA technology helping injured US troops
3. Bone marrow stem cells may heal hearts even years after heart attacks
4. Mice with glowing hearts shed light on how hearts develop
5. Free-radical busting antioxidants might not promote healthy hearts
6. UT Southwestern researchers find gene mutation that leads to broken hearts
7. Adult stem cell research at UB targets damaged hearts
8. Newts which regrow their hearts
9. Mechanical artificial hearts can remove need for heart transplant by returning heart to normal
10. Mutation improves memory, may lead to memory-enhancing pill
11. Researchers feed tiny pills of RNA to planarians to identify genes essential for regeneration

Post Your Comments:
(Date:11/30/2009)...ral Global Conference on Systems & Enterprises (GC... DC, focuses on the convergence of complex large-s...e to society. , The goal of the conference i... targeted complex systems, examined by domain, eac...tical Infrastructure Systems, including Intelligen...
(Date:11/30/2009)...inue to rise scientists are presented with the com...d and adapt. In a paper published in Insect Conse...lles and Dr Miguel Rodriguez assess this challenge...ately 0.6˚C has already affected the Earth,s ...s and evolutionary biologists is to predict how bi...
(Date:11/30/2009)...earch is the virus,s exquisite specialisation for ...al tools, like the humble lab mouse, can deliver o...s writing in BioMed Central,s open access Journal...s problem by creating a mouse that has key feature.... , George Kassiotis, from the Division of Immun...
Breaking Biology News(10 mins):First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2How can scientists measure evolutionary responses to climate change? 2A reductionist approach to HIV research 2Subaru Donates Hep B Hero Mobile to Support Campaign 59605 1Subaru Donates Hep B Hero Mobile to Support Campaign 59605 2Subaru Donates Hep B Hero Mobile to Support Campaign 59605 3NHS Human Services Receives Award from Health Ethics Trust 59600 1Dynatronics Will Request Hearing With Nasdaq Regarding Listing Status 5522 1
...hemotherapy significantly improves the survival ra...homa, according to a new study. , Published in th...science.wiley.com/cancer-newsroom ), a peer-review...dy reveals that combination therapy showed the gre...essive malignant non-Hodgkin,s lymphoma. This bene...
...us avoid becoming obese, such as "Eat less," and "...f advice based on a promising area of obesity rese...vidence that certain viruses may cause obesity, in...eah D. Whigham, the lead researcher in a new study...uses in vivo and in vitro in animals," in the Janu...
...,s Department of Plant Biology have found that pho...e hot springs have two radically different metabol...uit their day job of photosynthesis and unexpected...(N2) into compounds that are useful for cell growt...online edition of the Proceedings of the National ...
Other Biology News:Combination therapy improves AIDS-related lymphoma outcome 2Contagious obesity? Identifying the human adenoviruses that may make us fat 2Contagious obesity? Identifying the human adenoviruses that may make us fat 3Contagious obesity? Identifying the human adenoviruses that may make us fat 4Hot-spring bacteria flip a metabolic switch 2Hot-spring bacteria flip a metabolic switch 3
(Date:11/25/2009)... Ambassador to Speak at Econom...to, Canada (Vocus) November 25, 2009 -- Ambassador...: ,David Appia, French Ambassador for Internationa...n France Agency ,To view a biography of David Appi...assador Appia is available to meet with press to d...
(Date:11/25/2009)... , MARKHAM, ON, Nov. 25 /PRNewswire/ - Cytochr..., PhD to its Board of Directors. Dr. Moldt will re...ve on the Company,s Board. The number of Board mem...re very pleased to welcome Peter Moldt to the boar...ce and guidance as Cytochroma continues to make pr...
(Date:11/25/2009)... , NEW YORK, Nov. 25 Rep... report is available in its catalogue: ,, Braz...3 ,, http://www.reportlinker.com/p0165503/Bra...13.html ,, Brazil Bioethanol Market Analysis a...ort provides detailed analysis and forecasts of th...
(Date:11/24/2009)...is release is available in German . , Wheth... cards: RFID tags (Radio Frequency Identification)...life. They make it possible to label objects or go...ency. The appropriate scanner can read and process... be affixed to goods under production conditions o...
Breaking Biology Technology:French Ambassador for International Investment to Visit Toronto December 11 2Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10Intelligence inside metal components 2
...uarter 2008 Revenue Increased 7 Percent to $3.9 Bi... were $1.09, an Increase from Third Quart...ar Revenue Guidance Raised from $14.6 Billion - $1... $15.2 Billion, Full Year Adjusted EPS Guidance Ra...D OAKS, Calif., Oct. 22 Amgen (Nasdaq:,AMGN) repo...
...ARK, Calif., Oct. 22 StemCor Systems, Inc., a,med...g Regenerative,Medicine(TM), announced today that ...: HSP ) to develop and commercialize StemCor,s pr... (Logo: http://www.newscom.com/cgi-bin/prnh/20071...e System for Hospira, and Hospira will manage,the ...
...SBURG, Md., Oct. 22 MaxCyte, Inc., the pioneer,in...announces that it will,be launching the MaxCyte ST...Biomolecular Sciences (SBS) Symposium "Cell Based ...creening," to be held in King of Prussia, PA,on Th...n, MaxCyte will,sponsor the scientific session "As...
Other Biology Technology:Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23 2Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23 3Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23 4Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23 5Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23 6Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23 7Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23 8Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23 9Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23 10Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23 11Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23 12Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23 13Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23 14Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23 15Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23 16Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23 17Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23 18Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23 19Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23 20Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23 21Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23 22Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23 23Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23 24StemCor Signs Agreement With Hospira to Market New Medical Device to Oncologists and Hematologists 2StemCor Signs Agreement With Hospira to Market New Medical Device to Oncologists and Hematologists 3The MaxCyte STX Scalable Transfection System to be Launched at the SBS Symposium on Cell-Based Assays 2
DNA Engine Thermal Cycler Chassis, w/384-well block from Bio-Rad
Easy Cap Tool from Bio-Rad
...ides were designed to study protein expression pat... species. Tissue slices from three different spec...be treated as a single histological slide for H&E ...dization. This format allows a rapid analysis of ...
...ransfection reagent : jetPEI-RGD is a RGD peptide-...efficient transfection of integrin-expressing epit...on molecules involved in cell-cell and cell-matrix... and most aV-containing proteins, bind multiple Ar...
Biology Products: